Can Wellbutrin (bupropion) be used to treat anxiety and depression in a patient who is concerned about sexual side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Wellbutrin (Bupropion) for Depression with Sexual Side Effect Concerns

Bupropion is an excellent choice for treating depression when sexual side effects are a concern, as it causes significantly less sexual dysfunction than SSRIs and may even improve sexual function. 1

Sexual Side Effect Profile

Bupropion stands out among antidepressants for its favorable sexual side effect profile:

  • Significantly lower rates of sexual dysfunction compared to SSRIs, with relative risks of:

    • Sexual arousal disorder: 0.46 (54% reduction)
    • Orgasmic dysfunction: 0.22 (78% reduction)
    • Sexual desire disorder: 0.65 (35% reduction) 2

  • The FDA label explicitly notes that bupropion is associated with lower rates of sexual adverse events than fluoxetine and sertraline 1

  • Multiple systematic reviews confirm bupropion not only avoids sexual side effects but may actually enhance sexual function in certain individuals 3

Efficacy for Depression

Bupropion demonstrates equivalent antidepressant efficacy to SSRIs:

  • No significant differences in Hamilton Depression Rating Scale (HAM-D) or Clinical Global Impressions scores when compared head-to-head with SSRIs 2

  • American College of Physicians guidelines recommend selecting between CBT or second-generation antidepressants (including bupropion) based on patient preference, with strong emphasis on discussing adverse effect profiles 1

The Anxiety Question: Critical Nuance

This is where clinical judgment becomes essential. The evidence on bupropion and anxiety is mixed:

Reassuring evidence:

  • Recent 2025 systematic review found bupropion provides clinically relevant improvement in anxiety symptoms in adults with MDD, with generally comparable efficacy to SSRIs in most presentations 4
  • No clear signal of anxiety worsening was reported on validated anxiety measures 4
  • Hamilton Anxiety Scale scores showed no significant difference between bupropion and SSRIs (mean difference 0.37,95% CI -0.85 to 1.6) 2

Cautionary evidence:

  • SSRIs showed a modest advantage over bupropion in patients with HIGH baseline anxiety in pooled analyses 4
  • Bupropion's stimulating properties can provoke anxiety, particularly at higher doses 5
  • The FDA label warns about potential for agitation, anxiety, and insomnia as adverse reactions 6

Practical Clinical Algorithm

For depression with sexual side effect concerns:

  1. If anxiety is absent or mild-to-moderate: Bupropion is an excellent first-line choice

    • Start at 150 mg daily for 4 days, then increase to 300 mg daily 6
    • Monitor for activation symptoms in first 2 weeks

  2. If severe anxiety or anxious distress is prominent: Consider SSRI first, OR use bupropion with close monitoring

    • Start at lower dose (150 mg) and titrate slowly
    • SSRIs may have modest advantage in highly anxious subgroups 4
    • However, if sexual function is a priority, bupropion trial is still reasonable with careful follow-up

  3. If patient develops SSRI-induced sexual dysfunction: Add bupropion to reverse it

    • Well-established strategy with good tolerability 7
    • Can boost antidepressant response while reducing sexual side effects

Other Tolerability Advantages

Compared to SSRIs, bupropion has:

  • Lower rates of nausea (RR 0.6)
  • Lower rates of diarrhea (RR 0.31)
  • Lower rates of somnolence (RR 0.27) 2

Trade-off: Higher rates of insomnia, but generally manageable 4

Key Safety Monitoring

  • Screen for bipolar disorder history before initiating (can precipitate mania) 6
  • Seizure risk: avoid in patients with seizure disorders, eating disorders, or abrupt alcohol/benzodiazepine discontinuation 6
  • Monitor blood pressure, especially in first weeks 6
  • Watch for activation symptoms (agitation, anxiety, insomnia) particularly in first 2 weeks 6

Bottom Line

For depression with sexual side effect concerns, bupropion should be your first-line choice unless severe anxiety is present. Even with comorbid mild-to-moderate anxiety, bupropion is effective and well-tolerated when started at appropriate doses with monitoring. The sexual function advantage is substantial and evidence-based, making it the optimal selection when this is a patient priority. 1, 4, 2

References

3
Research

Bupropion in the depression-related sexual dysfunction: a systematic review.

CNS & neurological disorders drug targets, 2014

5
Research

Bupropion and Anxiety: A Brief Review.

Human psychopharmacology, 2025

Related Questions

Is bupropion extended‑release (XL) 150 mg appropriate for anxiety, and should the dose be increased to 300 mg?
In a 23-year-old male with anxiety and depression who smokes and wishes to quit, is bupropion (Wellbutrin) an appropriate treatment choice?
What is the appropriate initiation, titration, and monitoring plan for bupropion maintenance therapy in a 27-year-old woman with mixed anxiety and depressive disorder?
In a 59-year-old female nursing-home resident with depression, anxiety, and a history of alcohol abuse who is taking bupropion XL (bupropion) 300 mg daily, escitalopram 20 mg daily, trazodone 100 mg at bedtime and 25 mg in the morning, amphetamine/dextroamphetamine (Adderall) 10 mg daily, and divalproex sodium (Depakote) 250 mg twice daily, and who now presents with worsening depression, social isolation, increased daytime sleepiness, and anhedonia, what is the optimal psychotropic treatment approach?
What is the recommended dosing and monitoring plan for initiating bupropion in a 57‑year‑old male with anxiety‑dominant depression?
Which risk factors for prostate cancer indicate that screening should be initiated (e.g., age ≥55 years, African‑American ethnicity, first‑degree relative with early‑onset disease, BRCA1, BRCA2, or HOXB13 mutations, prior high‑grade prostatic intraepithelial neoplasia, atypical small acinar proliferation, or exposure to ionizing radiation or Agent Orange)?
Are doxycycline monohydrate and doxycycline hyclate clinically equivalent for treating cellulitis, and does one formulation have better gastrointestinal tolerability?
What types of sexual dysfunction are associated with fluoxetine (Prozac)?
Is HPV vaccination beneficial in patients who have previously undergone colposcopic treatment for CIN 1 or CIN 2?
How can aortic stenosis and mitral stenosis be diagnosed using cardiac point‑of‑care ultrasound (POCUS)?
Will the ejection fraction improve after recent surgical mitral valve replacement in a patient with severe mitral insufficiency and left ventricular systolic dysfunction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.